Astrana Health Inc
$ 29.23
0.55%
15 Apr - close price
- Market Cap 1,616,397,000 USD
- Current Price $ 29.23
- High / Low $ 29.75 / 28.64
- Stock P/E 63.20
- Book Value 15.94
- EPS 0.46
- Next Earning Report 2026-05-14
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.03 %
- ROE 0.04 %
- 52 Week High 34.80
- 52 Week Low 18.08
About
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. The company is headquartered in Alhambra, California.
Analyst Target Price
$36.00
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-03-02 | 2025-11-06 | 2025-08-07 | 2025-05-05 | 2025-02-25 | 2024-11-07 | 2024-08-07 | 2024-05-07 | 2024-02-27 | 2023-11-07 | 2023-08-07 | 2023-05-08 |
| Reported EPS | 0.4243 | 0.01 | 0.19 | 0.3424 | 0.367 | 0.33 | 0.4 | 0.31 | 0.26 | 0.47 | 0.28 | 0.31 |
| Estimated EPS | 0.104 | 0.47 | 0.35 | 0.3341 | 0.2136 | 0.32 | 0.39 | 0.3 | 0.15 | 0.33 | 0.25 | 0.31 |
| Surprise | 0.3203 | -0.46 | -0.16 | 0.0083 | 0.1534 | 0.01 | 0.01 | 0.01 | 0.11 | 0.14 | 0.03 | 0 |
| Surprise Percentage | 307.9808% | -97.8723% | -45.7143% | 2.4843% | 71.8165% | 3.125% | 2.5641% | 3.3333% | 73.3333% | 42.4242% | 12% | 0% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-14 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.24 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ASTH
2026-04-14 09:42:00
This article provides a price-driven insight into Apollo Medical Holdings Inc. (NASDAQ: ASTH) for rule-based trading strategies, highlighting strong near- and mid-term sentiment but a weak long-term outlook. It presents AI-generated signals and three distinct institutional trading strategies for different risk profiles. The analysis points to elevated downside risk due to a lack of additional long-term support signals.
2026-04-03 08:32:00
This article analyzes Apollo Medical Holdings Inc. (NASDAQ: ASTH) using AI models to provide trading strategies. It highlights a positive near-term sentiment that may shift, a mid-channel oscillation pattern, and an exceptional risk-reward setup targeting a 20.0% gain. Three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—are detailed, along with multi-timeframe signal analysis for different horizons.
2026-03-13 12:39:18
Astrana Health (ASTH), formerly Apollo Medical Holdings, is drawing attention after its rebranding, despite mixed shareholder returns with a 20.65% 30-day gain contrasted by a 20.36% one-year decline. Analysts view the company as potentially undervalued, with a fair value estimate of $35.67 against a current price of $23.25, while also highlighting risks related to Medicare/Medicaid reliance and execution challenges for full-risk contracts. Investors are encouraged to assess the company's valuation, considering both its discounted price target and its high P/E ratio.
2026-03-12 05:52:39
This article provides an in-depth analysis of Apollo Medical Holdings Inc. (NASDAQ: ASTH) based on AI models from Stock Traders Daily. It highlights near-term weak sentiment, exceptional risk-reward setups, and outlines three distinct trading strategies: Position Trading, Momentum Breakout, and Risk Hedging. The analysis includes multi-timeframe signal data and emphasizes real-time institutional-grade signals for risk management and optimized position sizing.
2026-03-12 00:39:47
Foothill Regional Medical Center, a part of Astrana Health, Inc., has been awarded the 2026 Patient Safety Excellence Award from Healthgrades, marking its fourth consecutive year receiving this recognition. This places the medical center among the top 5% in the nation for patient safety. The hospital also earned other distinguished Healthgrades awards for joint replacement and treatment of sepsis, highlighting its commitment to patient outcomes and quality care.
2026-03-02 17:53:13
Astrana Health (formerly Apollo Medical Holdings) reported Q4 2025 earnings, exceeding revenue expectations with $950.5 million. While GAAP EPS matched forecasts, the company's adjusted EBITDA outlook for the full 2026 financial year is slightly below current market expectations. The healthcare services company, which operates a technology-powered platform for physician-led care, has shown significant sales growth over the past five years.
